Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 14/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PKLR | P30613 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24286487 | 0.91 | PKM (0.46) | RORCPKMPKLRKMT2APAX8 | |
| SCHEMBL24286520 | 0.90 | PKM (0.46) | RORCPKMPKLRKMT2APAX8 | |
| SCHEMBL24286274 | 0.88 | PKM (0.47) | RORCPKMPKLRKMT2APAX8 | |
| SCHEMBL24286559 | 0.86 | PKM (0.45) | RORCPKMPKLRKMT2APAX8 | |
| SCHEMBL24286232 | 0.85 | RORC (0.51) | RORCPKMPKLRNPC1KMT2A | |
| SCHEMBL24286755 | 0.85 | RORC (0.59) | RORCPKMPKLRNPC1KMT2A | |
| SCHEMBL24286219 | 0.84 | RORC (0.56) | RORCPKMPKLRNPC1KMT2A | |
| SCHEMBL24286258 | 0.83 | PKM (0.47) | RORCPKMPKLRNPC1KMT2A | |
| SCHEMBL24286347 | 0.83 | RORC (0.64) | RORCPKMPKLRNPC1KMT2A | |
| SCHEMBL24287208 | 0.82 | PKM (0.46) | RORCPKMPKLRKMT2APAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307738-B1 | ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE | UNIV MICHIGAN REGENTS (US) | 2022-04-20 | — | — | EP | disclosed |